• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,370
2,300
1,860
1,850
1,725

COUNTRY

867
650
270
253
211

CATEGORIES

  • 858
  • 186
  • 679
  • 1,126
  • 391
  • 270
  • 252
  • 65
  • 378
  • 693
  • 1,330
  • 1,355
  • 625
  • 884
  • 1,695
  • 2,677
  • 507
  • 732
  • 0
  • 93

PRICE

6,792
11,418
17,941
25,150

PUBLISHED

1,984
2,685
7,337
25,150

PRODUCT TYPE

21,027
2,901
871
164
75
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Immunovaccine Inc.,(IMV) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Immunovaccine Inc.,(IMV) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Immunovaccine Inc.,(IMV) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Immunovaccine Inc. (IMV), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Tesaro Inc,(TSRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Tesaro Inc,(TSRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Tesaro Inc,(TSRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Tesaro Inc (TSRO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
TherapeuticsMD Inc,(TXMD) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages TherapeuticsMD Inc,(TXMD) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

TherapeuticsMD Inc,(TXMD) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for TherapeuticsMD Inc (TXMD), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Trius Therapeutics Inc,(TSRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Trius Therapeutics Inc,(TSRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Trius Therapeutics Inc,(TSRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Trius Therapeutics Inc (TSRX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Vanda Pharmaceuticals, Inc.,(VNDA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Vanda Pharmaceuticals, Inc.,(VNDA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Vanda Pharmaceuticals, Inc.,(VNDA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Vanda Pharmaceuticals, Inc. (VNDA), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
VG Life Sciences Inc,(VGLS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages VG Life Sciences Inc,(VGLS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

VG Life Sciences Inc,(VGLS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for VG Life Sciences Inc (VGLS), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Radient Pharmaceuticals Corp,(RXPC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Radient Pharmaceuticals Corp,(RXPC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Radient Pharmaceuticals Corp,(RXPC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Radient Pharmaceuticals Corp (RXPC), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Repros Therapeutics Inc,(RPRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Repros Therapeutics Inc,(RPRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Repros Therapeutics Inc,(RPRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Repros Therapeutics Inc (RPRX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
S&W Seed Co,(SANW) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages S&W Seed Co,(SANW) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

S&W Seed Co,(SANW) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for S&W Seed Co (SANW), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Seattle Genetics,(SGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Seattle Genetics,(SGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Seattle Genetics,(SGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Seattle Genetics (SGEN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
SignPath Pharma, Inc.,(SGTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages SignPath Pharma, Inc.,(SGTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

SignPath Pharma, Inc.,(SGTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for SignPath Pharma, Inc. (SGTH), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Spectral Diagnostics Inc,(SDI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Spectral Diagnostics Inc,(SDI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Spectral Diagnostics Inc,(SDI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Spectral Diagnostics Inc (SDI), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
American Bio Medica Corporation,(ABMC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages American Bio Medica Corporation,(ABMC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

American Bio Medica Corporation,(ABMC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for American Bio Medica Corporation (ABMC), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
AmpliPhi Biosciences Corporation,(APHB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages AmpliPhi Biosciences Corporation,(APHB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

AmpliPhi Biosciences Corporation,(APHB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AmpliPhi Biosciences Corporation (APHB), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Anthera Pharmaceuticals Inc,(ANTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Anthera Pharmaceuticals Inc,(ANTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Anthera Pharmaceuticals Inc,(ANTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Anthera Pharmaceuticals Inc (ANTH), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
ARYx Therapeutics, Inc.,(ARYX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages ARYx Therapeutics, Inc.,(ARYX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

ARYx Therapeutics, Inc.,(ARYX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ARYx Therapeutics, Inc. (ARYX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Bioanalytical Systems Inc,(BASI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Bioanalytical Systems Inc,(BASI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Bioanalytical Systems Inc,(BASI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Bioanalytical Systems Inc (BASI), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Bioheart Inc,(BHRT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Bioheart Inc,(BHRT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Bioheart Inc,(BHRT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Bioheart Inc (BHRT), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
DelSite Inc.,(DSIIQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages DelSite Inc.,(DSIIQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

DelSite Inc.,(DSIIQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for DelSite Inc. (DSIIQ), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Diasorin,(DSRLF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Diasorin,(DSRLF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Diasorin,(DSRLF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Diasorin (DSRLF), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos